Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cori Wijaya

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Archives of Biochemistry and Biophysics|July 2, 2008
Characterization of the prostaglandin H2 mimic: binding to the purified human thromboxane A2 receptor in solutionKe-He Ruan, Cori Wijaya, Vanessa Cervantes, et al.
Journal of Visualized Experiments : Jove|March 5, 2011
Acute myocardial infarction in ratsYewen Wu, Xing Yin, Cori Wijaya, et al.
The FEBS Journal|November 22, 2008
An active triple-catalytic hybrid enzyme engineered by linking cyclo-oxygenase isoform-1 to prostacyclin synthase that can constantly biosynthesize prostacyclin, the vascular protectorKe-He Ruan, Shui-Ping So, Vanessa Cervantes, et al.
Cardiovascular Drugs and Therapy|May 13, 2011
Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusionMing-He Huang, Yewen Wu, Vincent Nguyen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Archives of Biochemistry and Biophysics|July 2, 2008
Characterization of the prostaglandin H2 mimic: binding to the purified human thromboxane A2 receptor in solutionKe-He Ruan, Cori Wijaya, Vanessa Cervantes, et al.
Journal of Visualized Experiments : Jove|March 5, 2011
Acute myocardial infarction in ratsYewen Wu, Xing Yin, Cori Wijaya, et al.
The FEBS Journal|November 22, 2008
An active triple-catalytic hybrid enzyme engineered by linking cyclo-oxygenase isoform-1 to prostacyclin synthase that can constantly biosynthesize prostacyclin, the vascular protectorKe-He Ruan, Shui-Ping So, Vanessa Cervantes, et al.
Cardiovascular Drugs and Therapy|May 13, 2011
Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusionMing-He Huang, Yewen Wu, Vincent Nguyen, et al.
Pageof 1